To test whether AKT regulates CyclinB1 in HNSCC cells, we treated FaDu cells with a pharmacological AKT inhibitor LY294002 for 24 h, and then collected protein lysates for immunoblotting. Here, AKT1 is linked to head and neck squamous cell carcinoma.